Alnylam awaits FDA decisions on Amvuttra & Fitusiran next month, poised to boost revenue, profitability, and share growth.

Aurora Pharmaceutical is pleased to announce the availability of EquiCoxib, the FDA-approved generic equivalent of Equioxx® (firocoxib), a non-steroidal anti-inflammatory drug (NSAID) used for pain ...

As Alnylam Pharmaceuticals approaches its highly anticipated March 23 FDA decision date for a potential expansion of Amvuttra ...

Crispr Therapeutics AG has revenue declines but holds strong financials. Promising Sickle Cell therapy & 2025 data readouts ...

Torrent Group has acquired a 67% stake in IPL franchise Gujarat Titans for Rs 5,000 crore, with CVC Capital Partners retaining 33%. The acquisition will be funded internally, and Torrent is ...

Net income of $0.8 millionAdjusted EBITDA1 of $1.3 millionPediatric Portfolio net revenue up 86% sequentiallyFirst quarterly sequential prescription increase for both ADHD and Pediatric portfolios sin ...

Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) shares soared to a 52-week high, reaching a price level of $134.24, signaling a robust performance that has caught the attention of investors. The company's ...

While the continued erosion of Biogen’s multiple sclerosis franchise and weaker-than-expected 2025 guidance doesn’t seem to ...

This week's Mane Street Memphis covers updates on a proposed Chick-fil-A in Downtown and a new Madison Avenue restaurant.

The UFL season will kick off next month. Here's why the league is committed to the Memphis Showboats heading into 2025.

To illustrate that point, let's discuss two stocks in the biotech industry that have moved in opposite directions so far this ...